IntroductionOptimal surgical approach for the treatment of resectable lung cancer accompanied by coronary artery disease (CAD) remains a contentious issue. In this study, we present our cases that were operated simultaneously for concurrent lung cancer and CAD.MethodsSimultaneous off-pump coronary artery bypass surgery (OPCABG) and lung resection were performed on 10 patients in our clinic due to lung cancer accompanied by CAD. Demographic features of patients, operation data and postoperative results were evaluated retrospectively.ResultsMean patient age was 63.3 years (range 55-74). All patients were male. Six cases of squamous cell carcinoma, three of adenocarcinoma and one case of large cell carcinoma were diagnosed. Six patients had single-vessel CAD and 4 had two-vessel CAD. Three patients underwent OPCABG at first and then lung resection. The types of resections were one right pneumonectomy, three right upper lobectomies, one right lower lobectomy, three left upper lobectomies, and two left lower lobectomies. Reoperation was performed in one patient due to hemorrhage. One patient developed intraoperative contralateral tension pneumothorax. One patient died due to acute respiratory distress syndrome at the early postoperative period.ConclusionSimultaneous surgery is a safe and reliable option in the treatment of selected patients with concurrent CAD and operable lung cancer.

No abstract

Introduction: The objective of the present study was to elucidate whether high left ventricular mass index (LVMI) affects early outcomes after sutureless bioprosthetic aortic valve replacement (AVR) in aortic stenosis (AS). Patients and Methods: Postoperative early outcomes of 60 high-risk patients with aortic valve stenosis after replacement with sutureless bioprosthetic valve were retrospectively analyzed. Patients were grouped into two depending on LVMI. Left ventricular (LV) mass was calculated using the Devereux formula and indexed to the body surface area. High LVMI was defined as LVMI > 134 g/m 2 for males and LVMI > 100 g/m 2 for females. Early outcomes of surgery were compared between the normal and high LVMI patient groups. Results: Preoperative patient characteristics were similar between the groups. Early mortality was 8.3%. There was no statistically significant difference between the groups with respect to postoperative early complication rates and mortality. LVMI decreased from 114.7 ± 13.7 g/m 2 at baseline to 109 ± 32.2 g/m 2 at follow-up in group I (p= 0.60) and from 192.5 ± 31.9 g/m 2 at baseline to 117.9 ± 25.2 g/m 2 in group II (p< 0.001). Conclusion: The impact of high LVMI on morbidity and mortality after AVR with sutureless bioprosthetic valve was not deleterious in patients with isolated AS. Significant reduction in LVMI at 6 months is encouraging for these high-risk patients with severe LV hypertrophy; however, long-term follow-up is required.